ARDX Stock Analysis: Buy, Sell, or Hold?
ARDX - Ardelyx, Inc.
$5.99
0.44 (7.93%)
▲
5d:
+11.96%
30d:
-7.42%
90d:
+3.63%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Distribution
ARDX is up 4.5% this week, but smart money is buying puts. Top strike: $5 2026-05-15 with 125 OI. Put ratio: 80% View Scanner →
Strength: 5.2/10
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -25.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -25.1% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.40
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.77
62.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $5.99, which is considered fair relative to its 30-day fair value range of $5.52 to $6.36. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.5) compared to its historical average (27.3). Remarkably, the market is currently pricing in an annual earnings decline of 25.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is approaching resistance at $6.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: ARDX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.10 (+168.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is approaching resistance at $6.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: ARDX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.10 (+168.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.52 -
$6.36
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.9%)
- BULLISH: Trading 168.8% below Wall St target ($16.10)
Fair Price Analysis
30-Day Fair Range
$5.52 -
$6.36
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.00
Resistance Level
$6.02
Current Trend
Strong Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.48
Wall Street Target
$16.10
(+168.8%)
Revenue Growth (YoY)
7.8%
Profit Margin
-15.1%
Valuation Discount vs History
-25.1% cheaper
PE vs Historical
11.5 vs 27.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-25.1%
(market-implied from PE analysis)
1-Year Target
$5.39
(-10%)
2-Year Target
$4.85
(-19%)
3-Year Target
$4.37
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→27)
$10.38
(+73%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 4008.7%)
$39.36
(+557%)
Base:
(SPY PE: 11.5, Growth: 4008.7%)
$20.22
(+238%)
Bear:
(PE: 9.8, Growth: 4008.7%)
$17.18
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.5 to 27.3
Stabilization Target:
$14.25
(+137.8%)
PE Expansion Potential:
+137.8%
Share & Embed Analysis
Last updated: April 01, 2026 1:35 AM ET
Data refreshes hourly during market hours. Next update: 2:35 AM
Data refreshes hourly during market hours. Next update: 2:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab
SELL
41666 shares
2026-03-16
David M Mott
BUY
333333 shares
2026-02-20
Susan Hohenleitner
SELL
2033 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 55 HOLD |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
